Aktis Oncology, Inc. · NASDAQ:AKTS
Czibere Akos sold 50,000 Aktis Oncology, Inc. shares (Form 4)
Traded Jul 8, 2026 · Filed Jul 10, 2026
On Jul 8, 2026, Czibere Akos (Chief Medical Officer) sold 50,000 Aktis Oncology, Inc. shares at an average US$27.77 for US$1.39M, leaving 0 shares. Filed Jul 10, 2026 (Form 4).
- Sold
- 50,000 shares
- Price
- US$27.77 average (US$27.13 to US$28.71)
- Value
- US$1.39M
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | Option exercise | 50,000 | US$4.95 | 50,000 | Direct |
| Jul 8, 2026 | Common Stock | Sale | 14,800 | US$27.13 | 35,200 | Direct |
| Jul 8, 2026 | Common Stock | Sale | 30,829 | US$27.95 | 4,371 | Direct |
| Jul 8, 2026 | Common Stock | Sale | 4,371 | US$28.71 | 0 | Direct |
Source
Related
- Aktis Oncology, Inc.
- Czibere Akos
- Aktis Oncology, Inc. shareholders
- Form 4 · Czibere Akos · Sep 24, 2026
- Form 4 · Herrmann Ken · Jul 21, 2026
- Form 4 · Herrmann Ken · Jul 20, 2026
- Form 4 · Ron-Bigger Shulamit · Jul 10, 2026
- Schedule 13G · Blue Owl Capital Holdings LP · May 14, 2026
- Schedule 13D · EcoR1 Capital, LLC · Jan 20, 2026